Topics
New Perspectives in Ocular Oncology
Applying New Data to Improve the Standard of Care in Retinal Diseases
Supported by an unrestricted educational grant from Allergan, Inc.
View Supplement
Retina 2.0
Current Management of Vitreomacular Interface Disorders
Supported by an unrestricted educational grant from ThromboGenics
Retina Imaging and Visualization
Strategies and Outcomes With Pharmacologic Vitreolysis: Perspectives From Clinical Practice
Applying New Data to Improve the Standard of Care in Retinal Diseases: The Management of Retinal Vein Occlusions
The Path to the Retina
Wide-angle Viewing for Vitreoretinal Surgery
Sponsored by Oculus
View Insert
Uveitis Update 2013
Sponsored by Bausch + Lomb
Anti-VEGF Therapy for Diabetic Macular Edema
Supported by an unrestricted educational grant from Genentech
Current and Emerging Science in Age-Related Macular Degeneration
Injection Techniques for OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg
Sponsored by Allergan
EVA: A State-of-the-art Surgical System for Phaco-Vitrectomy
Sponsored by DORC
Updates on The Management of AMD and RVO: An Evidence-based Approach
Supported by an unrestricted educational grant from Regeneron
Diseases of the Retinal Vasculature
Applying New Data to Improve the Standard of Care in Retinal Disease
Supported by an educational grant from Allergan Inc.
Updates in Pediatric Retina
Current Treatment Options for Vitreomacular Adhesion and Macular Hole
Supported by Alcon and ThromboGenics
Vitreoretinal Surgery Updates
Free Print Subscription
Email Newsletter
Conference Calendar
November 17, 2026
MacuMira Receives CE Mark Certification for Retinal Microcurrent Stimulation Device to Treat Dry AMD
November 16, 2026
Johnson & Johnson to Acquire Ollin Biosciences for $2.2 Billion, Advancing Retinal Disease Pipeline
RetinaLyze System Receives EU MDR Class 2a Certification for Retinal Screening Software
November 11, 2026
AAO, AOA Respond to FDA GLP-1 Drug Labeling Changes, Highlight NAION Risk and Eye Care Recommendations